These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31092882)

  • 1. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
    Scharpenseel H; Hanssen A; Loges S; Mohme M; Bernreuther C; Peine S; Lamszus K; Goy Y; Petersen C; Westphal M; Glatzel M; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2019 May; 9(1):7406. PubMed ID: 31092882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of different CTC subpopulations in non-small cell lung cancer.
    Hanssen A; Wagner J; Gorges TM; Taenzer A; Uzunoglu FG; Driemel C; Stoecklein NH; Knoefel WT; Angenendt S; Hauch S; Atanackovic D; Loges S; Riethdorf S; Pantel K; Wikman H
    Sci Rep; 2016 Jun; 6():28010. PubMed ID: 27302574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor-targeted immunomagnetic liposomes for circulating tumor cell enumeration in non-small cell lung cancer treated with epidermal growth factor receptor-tyrosine kinase inhibitors.
    Cui S; Ni Y; Zhao Y; Li Z; Xiong L; Liu J; Liang X; Jiang L
    Lung Cancer; 2019 Jun; 132():45-53. PubMed ID: 31097093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors.
    Sun M; Behrens C; Feng L; Ozburn N; Tang X; Yin G; Komaki R; Varella-Garcia M; Hong WK; Aldape KD; Wistuba II
    Clin Cancer Res; 2009 Aug; 15(15):4829-37. PubMed ID: 19622585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary Study on Detection of Circulating Tumor Cells in Lung Cancer by EGFR/Vimentin/Folic Acid Magnetic Sphere].
    Li G; Wang Y; Tan G; Liu Y; Xu Z; Feng H; Xing W; Xu Z
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):351-359. PubMed ID: 32336066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
    Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
    PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC.
    Lim M; Park J; Lowe AC; Jeong HO; Lee S; Park HC; Lee K; Kim GH; Kim MH; Cho YK
    Theranostics; 2020; 10(12):5181-5194. PubMed ID: 32373206
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.
    Marchetti A; Del Grammastro M; Felicioni L; Malatesta S; Filice G; Centi I; De Pas T; Santoro A; Chella A; Brandes AA; Venturino P; Cuccurullo F; Crinò L; Buttitta F
    PLoS One; 2014; 9(8):e103883. PubMed ID: 25137181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients.
    Breitenbuecher F; Hoffarth S; Worm K; Cortes-Incio D; Gauler TC; Köhler J; Herold T; Schmid KW; Freitag L; Kasper S; Schuler M
    PLoS One; 2014; 9(1):e85350. PubMed ID: 24465542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent overexpression of ErbB--receptor family members in brain metastases of non-small cell lung cancer patients.
    Berghoff AS; Magerle M; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckman K; Marosi C; Wöhrer A; Hackl M; Zöchbauer-Müller S; Preusser M; Birner P
    APMIS; 2013 Dec; 121(12):1144-52. PubMed ID: 23756255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
    Watanabe M; Kenmotsu H; Ko R; Wakuda K; Ono A; Imai H; Taira T; Naito T; Murakami H; Abe M; Endo M; Nakajima T; Koh Y; Takahashi T
    Cancer Sci; 2018 Aug; 109(8):2539-2548. PubMed ID: 29900633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
    Wei T; Zhu D; Yang Y; Yuan G; Xie H; Shen R
    PLoS One; 2019; 14(7):e0219129. PubMed ID: 31344053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors.
    Jiang T; Zhao J; Zhao C; Li X; Shen J; Zhou J; Ren S; Su C; Zhou C; O'Brien M
    Clin Lung Cancer; 2019 Mar; 20(2):124-133.e2. PubMed ID: 30587399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.
    Beck TN; Boumber YA; Aggarwal C; Pei J; Thrash-Bingham C; Fittipaldi P; Vlasenkova R; Rao C; Borghaei H; Cristofanilli M; Mehra R; Serebriiskii I; Alpaugh RK
    BMC Cancer; 2019 Jun; 19(1):603. PubMed ID: 31215484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.
    Bian J; Yan K; Liu N; Xu X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2621-2630. PubMed ID: 32661602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic
    Yu HA; Yang JC; Hayashi H; Goto Y; Felip E; Reck M; Vigliotti M; Dong Q; Cantero F; Fan PD; Kanai M; Sternberg DW; Jänne PA
    Future Oncol; 2023 Jun; 19(19):1319-1329. PubMed ID: 37212796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Single Cell Gene Expression and EGFR Mutation Analysis of Circulating Tumor Cells Reveals Distinct Phenotypes in NSCLC.
    Owen S; Lo TW; Fouladdel S; Zeinali M; Keller E; Azizi E; Ramnath N; Nagrath S
    Adv Biosyst; 2020 Aug; 4(8):e2000110. PubMed ID: 32700450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.